Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLC

NCT07554846 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

759

Enrollment

OTHER

Sponsor class

Conditions

Resectable Stage II-IIIa NSCLC

Interventions

DRUG: Peroperative immunotherapy
DRUG: Neoadjuvant immunotherapy
DRUG: Adjuvant immunotherapy

Sponsor

Fudan University